Amgen and Adaptive Biotechnologies Announce Strategic Partnership to Develop a Therapeutic to Prevent or Treat COVID-19

Amgen (NASDAQ:AMGN) and Adaptive Biotechnologies (NASDAQ:ADPT) today announced a collaboration aimed at helping address the COVID-19 pandemic. The companies will combine expertise to discover and deve...

Learn More

Aktivax, Inc. has been awarded a $16 million contract from the Biomedical Advanced Research and Development Authority (BARDA)

Shortly after receiving a $24.5 million project from the Department of Defense (DOD) to develop a scopolamine auto-injector, Aktivax, Inc. has been awarded a $16 million contract from the Biomedical A...

Learn More

Flagship Biosciences Hires New Vice President of Clinical Diagnostics

Flagship Biosciences, providers of expert tissue data insights, today announced that Geoff Metcalf, MBA, PMP, will join its executive team as Vice President Clinical Diagnostics. Geoff brings 25 years...

Learn More

SOPHiA GENETICS and Paragon Genomics Join Forces Against COVID-19 Coronavirus Pandemic

SOPHiA GENETICS, leader in Data-Driven Medicine, today announced that it is entering the fight against the COVID-19 coronavirus by extending its partnership with Paragon Genomics, who developed a next...

Learn More

Aktivax, Inc. Awarded a $24.5M US Government Project

Aktivax, Inc. has been awarded a $24.5 million US government project to develop an autoinjector treatment for exposure to nerve agents. The award is an Other Transaction (OT) prototype project by the...

Learn More

PharmaJet Received Multi-Year, Multi-Million Dollar Award to Support Next-Generation Needle-free Delivery Devices

PharmaJet®, the maker of innovative, needle-free injection technology, announced that it received a $9.6 million dollar contract award from the Joint Science and Technology Office of the U.S. Defense...

Learn More

Pfizer Outlines Five-Point Plan to Battle COVID-19

Chairman and CEO Albert Bourla Calls on Biopharma Industry to Collaborate on Combatting the Global Pandemic. Read the plan here.

Learn More

Biodesix Announces New Commercial Organization and Executive Appointments

Biodesix, Inc., a leading diagnostic company in lung cancer, today announced the realignment of their commercial executive team. Kieran O’Kane will be promoted to Chief Commercial Officer (CCO) and Bo...

Learn More

CSU, Zoetis leaders herald launch of new research lab

Officials from Zoetis, the world’s leading animal health company, and Colorado State University gathered on the Foothills Campus on Jan. 28 to celebrate the opening of a new lab. The 3,000-square-foot...

Learn More

New Investments Boost Colorado's Life Sciences Community

The Rockies Venture Club and Colorado BioScience Association (CBSA) announced a partnership to mobilize Colorado’s capital resources to support early-stage bioscience companies in the state.  “Co...

Learn More